Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Non Operating Income (2020 - 2025)

Historic Non Operating Income for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $89563.0.

  • KORU Medical Systems' Non Operating Income fell 2687.54% to $89563.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $384909.0, marking a year-over-year decrease of 2910.08%. This contributed to the annual value of $444642.0 for FY2024, which is 2078.75% down from last year.
  • KORU Medical Systems' Non Operating Income amounted to $89563.0 in Q3 2025, which was down 2687.54% from $123144.0 recorded in Q2 2025.
  • KORU Medical Systems' Non Operating Income's 5-year high stood at $648211.0 during Q4 2021, with a 5-year trough of -$18139.0 in Q2 2022.
  • In the last 5 years, KORU Medical Systems' Non Operating Income had a median value of $93434.0 in 2024 and averaged $110314.4.
  • Per our database at Business Quant, KORU Medical Systems' Non Operating Income surged by 196403.76% in 2021 and then plummeted by 26211.46% in 2022.
  • Over the past 5 years, KORU Medical Systems' Non Operating Income (Quarter) stood at $648211.0 in 2021, then plummeted by 84.42% to $101008.0 in 2022, then surged by 67.54% to $169230.0 in 2023, then crashed by 44.79% to $93434.0 in 2024, then fell by 4.14% to $89563.0 in 2025.
  • Its last three reported values are $89563.0 in Q3 2025, $123144.0 for Q2 2025, and $78768.0 during Q1 2025.